The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system

Journal of Clinical Microbiology

Volumn 36, Issue 7, 1998, Pages 2046-2051

  Touze, Antoine ^a   Mehdaoui, Slimane E L ^a,b   Sizaret, Pierre Yves ^c   Mougin, Christine ^d   Muñoz, Nubia ^e   Coursaget, Pierre ^a,c  

^a INSERM   (France)

^b UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^c UNIVERSITÉ DE TOURS   (France)

^d UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ARTICLE; CROSS REACTION; IMMUNOGENICITY; INSECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; STRAIN DIFFERENCE; VACCINE PRODUCTION; VIRUS CHARACTERIZATION; WART VIRUS;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; INSECTA; MIRIDAE;

EID: 0031836209     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.7.2046-2051.1998     Document Type: Article

References (31)

1. Baker, T. S., W. W. Newcomb, N. H. Olson, L. M. Cowsert, C. Olson, and J. C. Brown. 1991. Structures of bovine and human papillomavirus: analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 60:1445-1456.
2. Bell, J. A., J. P. Sundberg, S. J. Ghim, J. Newsome, A. B. Jenson, and R. Schlegel. 1994. A formalin-inactivated vaccine protects against mucosal papillomavirus infection: a canine model. Pathobiology 62:194-198.
3. Bonnez, W., R. C. Rose, C. DaRin, C. Borkhuis, K. L. De Mesy Jensen, and R. C. Reichman. 1993. Propagation of human papillomavirus type 11 in human xenocrafts using the severe combined immunodeficiency (SCID) mouse to the nude mouse model. Virology 197:455-458.
4. Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Demarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
5. Chan, S. Y., L. Ho, C. K. Ong, V. Chow, B. Drescher, M. Dürst, J. ter Meulen, L. Villa, J. Luande, H. N. Mgaya, and H. L. Bernard. 1992. Molecular variants of human papillomavirus 16 from four continents suggest pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
6. Chan, S. Y., H. U. Bernard, C. K. Ong, S. C. Chan, B. Hofmann, and H. Delius. 1992. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase of the molecular evolution of DNA viruses. J. Virol. 66:5714-5725.
7. Cheng, G., J. P. Icenogle, R. Kirnbauer, N. L. Hubbert, M. E. Louis, C. Han, E. I. Svare, S. Krüger Kjaer, D. R. Lowy, and J. T. Schiller. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 172:1584-1587.
8. Christensen, N. D., J. W. Kreider, N. M. Cladel, S. D. Patrick, and P. A. Welsh. 1990. Monoclonal antibody-mediated neutralization of infectious human papillomavirus type 11. J. Virol. 64:5678-5681.
9. Christensen, N. D., and J. W. Kreider. 1990. Antibody-mediated neutralization in vivo of infectious papillomavirus. J. Virol. 64:3151-3156.
10. Christensen, N. D., C. A. Reed, N. M. Cladel, R. Han, and J. W. Kreider. 1996. Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J. Virol. 70: 960-965.
11. Favre, M., N. Ramoz, and G. Orth. 1997. Human papillomavirus: general features. Clin. Dermatol. 15:181-198.
12. Hagensee, M. E., N. Yaegashi, and D. A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J. Virol. 67:315-322.
13. Ho, L., S. Y. Chan, R. D. Burk, B. C. Das, K. Fujinaga, J. P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, P. Mavromara-Nazos, V. Labropoulou, S. Mitrani-Rosenbaum, B. Norrild, M. Radhakrishna-Pillai, J. Stoerker, K. Svrjaenen, S. Syrjaenen, S. K. Tay, L. L. Villa, C. M. Wheeler, A. L. Williamson, and H. U. Bernard. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:6413-6423.
14. International Agency for Research on Cancer. 1995. Monographs on the evaluation of the carcinogenic risk of chemicals to humans, vol. 64. Human papillomavirus. International Agency for Research on Cancer, Lyon, France.
15. Jansen, K. U., M. Rosolowsky, L. D. Schultz, H. Z. Markus, J. C. Cook, J. J. Donnelly, D. Martinez, R. W. Ellis, and A. R. Shaw. 1996. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 13: 1509-1514.
16. Kirnbauer, R., F. Booy, N. Cheng, D. R. Lowy, and J. T. Schiller. 1992. Papillomavirus Ll major capsid protein self-assembles into virus-like particles that are immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
17. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Dürst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
18. Le Cann, P., P. Coursaget, S. Iochman, and A. Touzé. 1994. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol. Lett. 117:269-274.
19. Li, M., T. P. Cripe, P. A. Estes, M. K. Lyon, R. C. Rose, and R. L. Garcea. 1997. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J. Virol. 71:2988-2995.
20. Moreland, R. B., L. Montross, and R. L. Garcea. 1991. Characterization of the DNA-binding properties of the polyomavirus capsid protein VP1. J. Virol. 65:1168-1176.
21. Neeper, M. P., K. J. Hofmann, and K. U. Jansen. 1996. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisae. Gene 180:1-6.
22. Olson, C., D. Segre, and L. V. Skidmore. 1960. Further observations on immunity to bovine cutaneous papillomatosis. Am. J. Vet. Res. 21:233-238.
23. Pisani, P., D. M. Parkin, N. Munoz, and J. Ferlay. 1997. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomark. Prev. 6:387-400.
24. Roden, R. B. S., H. L. Greenstone, R. Kirnbauer, F. P. Booy, J. Jessie, D. R. Lowy, and J. T. Schiller. 1996. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J. Virol. 70: 5875-5883.
25. Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. N. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
26. Seedorf, K., G. Krammer, M. Dürst, S. Suhai, and W. Rowenkamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
27. Suzich, J. A., S. J. Ghim, F. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
28. Trus, B. L., R. B. S. Roden, H. L. Greenstone, and J. T. Schiller. 1997. Novel structural features of bovine papillomavirus capsid revealed by a three-dimensional reconstruction to 9 A resolution. Nat. Struct. Biol. 4:413-420.
29. Unckell, F., R. E. Streeck, and M. Sapp. 1997. Generation and neutralization of pseudovirions of human papillomavirus type 33. J. Virol. 71:2934-2939.
30. Zhou, J., X. Y. Sun, D. J. Stenzel, and I. H. Frazer. 1991. Expression of recombinant HPV-16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 185:251-257.
31. zur Hausen, H. 1989. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49:4677-4681.